Listing announcement
hammold Pharmaceuticals Inc.
IPO Prospectus
November 1, 2018
hammold Pharmaceuticals Inc. (“hammold” or the “Company”) is pleased to announce the Initial Public Offering (“IPO”) of its common shares. The Company seeks to raise $75 million from this offering.
Overview
Founded in 2009, Ha......